THE SMART TRICK OF METFORMIN THAT NOBODY IS DISCUSSING

There have been no clinically important distinctions within the pharmacokinetics of possibly midazolam (CYP3A4 substrate) or repaglinide (CYP2C8 substrate) when applied concomitantly with finerenone. A number of doses of forty mg finerenone as soon as-daily had no clinically relevant effect on AUC or Cmax with the BCRP and OATP substrate rosuvastat